UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
(State or other jurisdiction | (Commission File Number) | (I.R.S. Employer | ||
of incorporation) | Identification No.) |
(Address of principal executive offices)
+1
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class | Trading Symbol | Name of Each Exchange on Which Registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth
company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07. Submission of Matters to a Vote of Security Holders.
On July 21, 2023, Enochian BioSciences Inc., a Delaware corporation (the “Company”), held its annual meeting of stockholders (the “Meeting”) as prescribed in the Proxy Statement filed by the Company with the Securities and Exchange Commission on May 16, 2023, as amended from time to time. At the Meeting, three proposals were submitted for a vote of the Company’s stockholders and the related results are as follows:
Proposal No. 1: The election of Renè Sindlev, Dr. Mark R. Dybul, Dr. Carol L. Brosgart, Gregg Alton, James Sapirstein, Henrik Gronfeldt-Sorensen and Jayne McNicol for terms until the next annual meeting of stockholders or until each such director’s successor shall have been duly elected and qualified. The stockholders elected each of the seven directors by the following votes:
Director | Votes For | Votes Withheld | Broker Non-Votes | |||||||||
Renè Sindlev | 18,661,936 | 166,766 | 1,528,369 | |||||||||
Dr. Mark R. Dybul | 18,662,825 | 165,877 | 1,528,369 | |||||||||
Dr. Carol L. Brosgart | 18,652,095 | 176,607 | 1,528,369 | |||||||||
Gregg Alton | 17,343,287 | 1,485,415 | 1,528,369 | |||||||||
James Sapirstein | 17,122,111 | 1,706,591 | 1,528,369 | |||||||||
Henrik Gronfeldt-Sorensen | 18,659,827 | 168,875 | 1,528,369 | |||||||||
Jayne McNicol | 17,247,573 | 1,581,129 | 1,528,369 |
Proposal No. 2: Approval of 2023 Equity Incentive Plan. The stockholders approved the 2023 Equity Incentive Plan as follows:
Votes For | 18,785,519 | |||
Votes Against | 34,914 | |||
Abstentions | 8,269 | |||
Broker Non-Votes | 1,528,369 |
Proposal No. 3: Ratification of Independent Registered Public Accounting Firm. The stockholders ratified Sadler, Gibb & Associates, LLC as the Company’s independent registered public accounting firm as follows:
Votes For | 20,327,508 | |||
Votes Against | 16,107 | |||
Abstentions | 13,456 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ENOCHIAN BIOSCIENCES INC. | ||
By: | /s/ Luisa Puche | |
Name: Luisa Puche Title: Chief Financial Officer |
Date: July 28, 2023
Cover |
Jul. 21, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Jul. 21, 2023 |
Entity File Number | 000-54478 |
Entity Registrant Name | ENOCHIAN BIOSCIENCES INC. |
Entity Central Index Key | 0001527728 |
Entity Tax Identification Number | 45-2559340 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 2080 Century City East |
Entity Address, Address Line Two | Suite 906 |
Entity Address, City or Town | Los Angeles |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 90067 |
City Area Code | (305) |
Local Phone Number | 918-1980 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.0001 per share |
Trading Symbol | ENOB |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
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end
&1,9$6-27ORI]4$Q6N[-:*2"Q>5NN.XQ'Y68*SK:UN3 MU4K_]&7;L:^0F 6*WK_L)C=^VS=-)F]5S+V.A9]X;"_<)391=W>F MC?RX?E8HKA_^ M/_[='N.F5.7KW!*RJ=!AIE),:'1/B9S(&-K8T5*136+%*X MYJ>A_4WQ#JIA14-5'3L.>K8JY!6CFBD@"1WJEE20O.&,2!:/S@6Y?NR M44J2A2D*C\,>W4J[_57KNF;NE=G,>3R1,@^^@FWL-C.5ARBPP49]K+L$_3<9 MYR>ID<6/7&M/55%N5NFF)N!ME6JKA>/(%P[?U'E&;DF$?GY"!B<=YX?VVFWN M&22B4O[P8[)_PV0'&AH8R.6'))K7_5/I6Q%K5;)6A34!3(O%U6%T1,K7FF_' M&]A1\:-G,= EMA\(0Q<7U15$YFUK8\;Y1/&0&KQ8!QK%L]38JG7/IO<:ZH;* MUZ$P._((*7SC@>-Z@*B B K/N4T!ZB# ZM83DX7=6USP#2^GK7X/@%VD$HZ MU/".C(A5;":9#=9/ A=]JL@\='UV>F@3XWA4G(OQ9O&UE]D*5 MJ0M7IB]SR87 ""F07L-L$/,9G U .)EB#Y#3!.7_D2 M?MO+5LWN.*X 9$U^5RG9'>[DXVGLS'4=N5_1,*7,@O,0-OZ' %P.BK MZ9T$#V(X=&KJ,/-.W%M86V\2 &991-'L:G,$]X0HG'@5[8Y'"%1_2@V M)SI4!\LH>X4B/OE(&-JYN NLZ<0^3LZ]\,S,)1ZA5"[@->#%/<^B=VRSAQC, M'1 G3,NP,#7)WS'8 "85Y-"R]C>3OI>WOY/J"KU_!=^8SEAP]0RI<1 M\/O<\>J^#Q2W0QA__2&EI?W=G3;8&)WTH^C(CHLU&VK%T=%(=G7O417;IHXN MXNC0-ITNMED4G8"G[Z**SJ]-0F>8#ZZ-+6H[C%!X L[O#';DN9M/@5P(^HSK0S^M >.+0<>$/ ME=HP0M.>B(JK@.([IDA3Z3I$)7T(76!)BU1N+X( A5/U"+C$<7@(( $/2MR!HD_V@Z?V?^?VA%R- #%NYO"TNG'/D<]C(%3YZ]G;!I)M<#@^":\#F2CJQ#"'>A#J_,VQ)*;L%P M 'XN4A[;..2;N'DN397IA?)FMEDJ%,E4QY N\WU$.C%23A6B MN5PJ6DSGEG5\.:[?,(I<+IK/O>\A1+-2(9K.%5\]B+5$_):GGD/D>A'E@F\. M"'Z28:MR:9F(2M&"E'VJ<1C0-Z,HEXT6\OFM(6>9Z+RAO*Q@$L-%9R&&^Q7B MDY6BR>+VB$\^%\TE_]7BL[JYF0KPWWY>HNE,.BH5MFAJ,H5L-)/:'M%]+Z9F M?BGX"V0G)4G15"JU/5.53^:BV>(6$;3-=F9IIN"7^* $>CU_7/B[.HN#X6GARAQIW?OSC:181%$R?!+AR99TJJ#*I_CFF=F^) M.[0%3.C5QJK.;Z\XH;*,_L(]:Q]5',=4^/4+3G1WY^*BRGUBV)XSG:)C ZA2Y52D;3$BP3DH4/ESJSQ(VF7IJ!_2>XU%0ZFLDN M[)/]&[S(DM,1*Q0K2A_%BILM5OQ= PLK9%99V#^$7!*QQ>B(;52HMZ) 6[CEBV4\?_/@_'(T,\ Y3!"]/[ M4(=,-*QW@F(C$5_Y#32(2B 0,7=W!#SL,LVTZ4^BQG\UHY8&)V]^4].BY0Z] M3>/I8AA)"&[P71BT^%D8>?$(ZJ80+_%^*X$?LR2[8M##2RX.1R44WN@I#!G> M->$DT(5+'0PAN<(_/[8YGCQ)_?070A>./(>B\+Y#/4VK_UE+<>"UA*H:)1VP MNL')@J:X@M)>YHRWQWIYG_PJ^170A> S6-MF9,.]_DI?D$UO]@.R4Q^Q6O,# ML9O@:8)_TYP+5$)C/;V\XA?4"X=WA!^C$9?T37UYG9P-C^^_)L\']Y4O6BWQ MI3D:9G5FGU!FG=*,];WU_;%N%X[=,U7KC4;RWZ>*+I_H_=J/V^,?/^S,C_J7 M'[1UP]1ZH6%] J>%FV'6E*\(4VY&VFUWI#>:VFGMY,8Z.C],?/U>^_8S>7_S]T/[7FT^ M'O:^GDM'S93=J%F=_LW98>+FX4M!LA]_FO0VF>QIU_22]!\:EZ:IYYO4/75: MWZKI'J&W1U^NVX>WUQ<=Z3;=_'FO6=]3C?O,!7/O$X/DW_5#=O:U^_FSQY+_ M U!+ P04 " UBOQ6YD^^MRT# #L"P $0 &5N;V(M,C R,S W,C$N M>'-DM5;; O@B@5VFT;L#-S!&-7!#:*(0\GX&7B")-46=HT) MXJ#%XH0@B90CCU0'QXY?@\"V=]!]0C1D_+';GNF.I$Q$W74GDXE#V1A.&'\1 M3L#BW01[$LI4S-2\J5<\N]%OL0AF9!=>]L7IM(N?A_?T4WH#:3_HP?CK"7R0 MOY-C'Z.7Z?BF_S%ZCF'TVJ:C">]&^,>WHZ/KRJ1_V\I#-D0P0C$$ZC"H:%JZ MOJ*\2=5A?.A6/,]WGV\[O0QGY<#ZEZL@[NUVHU-_,:: DY'7!BI*NN=@^@ M0#-EY<5;\)@*"6FPA _EC+ (/G9SYQ(4KX6>Y%!LH"%:P0D4.$,V=I5#X2M5 M TR%/80PF8$C* :9:.%8 @LNRT!E7 79\C5!8BTT=RT1OMS=7\ZPB+)@A"$= M8*;;,@-ZIQ5?#1=!,:+RFO'X"D4P)2J77RDD.,(HM("$?(BD[C.1P "]+6CZ M%5+*5%NKV2HLVI8D6/7MS*!,^ISKG!'T714 ]$+-U<8HVN^VF+H>+(##II4O M%_2,8H@B3'$6O1@E']AZ<%)=K%IFS(:["BXKI0*%]_0\6R<<"47/JNHH0\$O M(-NY 21!2@ZBSO/;QBSL9B]+FVPFJHLBD$UB7?=,TQ)8WX5681MQ%#4MM>\# MVQSI3U6VHWK*0'2$+9.8G='J3A6!C03D04FE=%,H$98@+K%J[(7K($\=2TU_ M6 @#=!QA ?5D[@8-_*%061_UAR1^N7:VVXR\.EWE<'L*'*95P"6AKF;==I M_B'HL""3VD+1;[;AV=ID^Q6[ZCM3$ )^0[LEX3A'9#$ADM]77RQ":X7 M60OM&G3#QV%KT+4<%Q$IC.7@%!8_)7^10R:S5Q)+QQE*[FH)+>K9GF_KC]6F M=-YB9N_BH"8(6$HE?]VG$18IYN6PTYC_!.QV$ :?'X+^+S@T[ %=4 Z^K@4: M;JZFEG\ 4$L#!!0 ( #6*_%89TA87_0H ("& 5 96YO8BTR,#(S M,# &ULS9U=;^.X%8;O"_0_<-V;%AC'XP0MD.QD%QE/LC VFV1C MSVS;1;&@)<810I,!)2?VOR\IB;)$\4A*BI* ;X3%7'R]GU?U/F;9 GD[Q42UO*W4I0O8^3 MB;93U2Q+DPY]S4F:G*6YO6L>X2SO]M[=(%"A_C?6LK':-)X>CT^F1[LT'NF# MGQ]!P2FY)P\H;^99MG^6**6)(F%4;GL4Y,%NA@HQ4?$31M8X([':T:G:T?0? M:D=_*3=?XQ6A(Z24D@^P7:>-NLJ@B6NS=T0D/+YD[W-M1GNR+[\[(OL?&E"/ M=]Z$)<\P?9?Y>J1SVS?D?4?\$.?^2,MQGKSO2- ^W&E:N.U M_-2P2':9G,!(K$VJ*CI&X'P/^<10UEW5SJ-&O52-YERTVZYFQKS.E$1':_XR MB4DBZSX^41_&ZD/>;/F?/V9 ".T+BZBG M<:5B$G$Y-3UG8UH -PB Z MV>;([.5*@Y3(5S=_(6DDDF>UG.]J1T/FO-,M)EM]7].$A4#;&$Q"3>MI8+\G MZT1-+ A*HH3QQ=,+;%])X\ M<]&%3U/FFAJ;21.6NB8H1BS&0#0*+2K$GHCX=2O/V(F@^UXH6DK77 !6330, M65!TV+V!@%1ROXPL!69IH@:P7DC:4N>G&X#9UJF'H0N*$\ $I2Z?V2LG@D ME*K[ 9CU#R@VL6M:8,,F+VUE4,2 ]D!F\@A4AH2#S>6+6IW+9=+ QM;T/N%I MV>[BIQ('BY#I<"!%>1A2<9Y(JMV&Z&&HI71-#V#5Y,:0!46,W1O(2B%'N=X_ M)) V: MD+2$08$"N0-A*0(T,WF(5V#^1; 8ADM-Z0>6EE4[*I4L0%!,;WV8*+T72&9; M(1JNX1D'ECJ[*=MCMKH_"^B" *7'7.NN;2%O@.)I!KID69+MU?-T-]O-B@A+ MX]H25VQ YC039GD0+ "F3 8*&5(Z5 B]]+R^2\ R]1 CV!Q3YI8 N\DF!4U- M0"18C0$T'+3Y,Z5>B)C)D4E@.F #>/ M):C)0U(\#]Y#":AW"TN/[28S@#@@=+H= @3)(-2,\@G2G$5//:XPXSOI4# MX'[&8WB%TA/E%JI!36BBU1D2$&!#? *8-4(_%,^D(*[>X\DK0*H&+\1=Q+$\ M4&GYSW7"R!1LOU7KEJX.NTVF+,* 2(+= ?R4R@_Z U(QZ):% LWQ&YIZ[!^: MXZ'0' <-S?%[H%F^\D"@.7E#4T_\0W,R%)J3H*$Y>1 %L4.D%F;95*S '67BXM+SUP:("U'I&A?C$)%]8W8H[P5\2%L%+9DCN!1C MM)4:0QL>.G:#??Q4"V(=YW6L*1;EO5\2+?,SRC1-VH>80A,>)$UCO8-+H?:) MQ!U/,TS_G3QWGHC;Q5[PL!JV0M)0AH>*S5X?,$4,DD$^3JQ+7-4-#>NK9$:Y MNU> +;8.KP#7"H. P.:H_0IP6D$+GN9L6H(!@8$9K%SCK98JKJXUI9&%W< M-M3JX?Q[+34^OL@JNPN]>^0,?D"@+7'5TY YW=MF>1 ]#I@R>SV7H5SGZ6J\ MRC"1VH?O6IFSF=VT4TWDNB"(WC7=M*9I7>ZX-W\322;W/..;S9:5=WELSPT" M.E>]W&E3][A5%$3O=SDS22BUJ"EVC,6"TR1*LH2M?Y$GGR+!ME;91*Z @ UJ M&MJ*(% ;9D<'(1(*QU#<">(@I#(CLA? E2)A<3MPX-UMN\2NX*BW["& U8& M 4FO/1,6&3".:A&H"$%YC%]LYFFZ)>)-\%A"/"$$F@= :NE#Q DRV0M5$>B3 MK06)MG)^W$^/5\LDH[:3R[;$V9P$F*MF)*,\"#8 4R8+>1GB#VAZ_-?5WY". M N]AO5IP"V:>L*E<0=%C4'%@D0: ^S)IN.&HE*)"ZR,[5<.L MI3E&N2L K+9TUS<*@^ATFZ/6E[_1UYZ&_,M=]"A-$>"%!+O,]=!O,VD._W5- M$ AT&&N=E)12I+4^7D@X3%GK_D7 VMLB8-VS"%B'N A8#UT$K+TM O1NBQ0A M MM)9%TKF:&"FU:RZV<9*1N#!SE3#,H@33 M*CVB[8IX?X@S6@::K\#IT8?!T#"3+9R*,)W+L H\I+IT?2F]> #C-T+ISXR_ ML@7!*6 O=/C'38[OYT P@#@*G(0Z!1V=4T/A)12$=5EX)\T+2 M-TZW+,,B?Y= 6',!FDQA#%! I=F< (948%6H_+V@7V2.J15;QNT-@ M R&YX]>U.TT;;VU;M0$QTVD0>H>[S/EQ6!L749Y>L 2N7ZKL,FV^36G3!H10IT'P_ =MFC"2PA.1H7++@M5BDX6&)" 6;+X M%G(ITEHO+%QNB%C+Z>TGP5^SQS(_*]@V0.V6C4[+34:LTH!8Z?(',*-#4!&C M4^KZ@6=W2"A>9%F$6VJ1.L8&-&LPT]*%! QDKD4+)9&ZWG+#,[3DZ&M*4/9( MT&7Y,W3U3/!%/;Y^:22*U L1Q:J ;F&=D [[MT!_BBJ"AYC5'??H@:!IHTF0J#VN>7.>! M2$7ZS&943VX/+_$:(L MP-MMEJH95!J#KX)W!CF^O3"@ <9-AHZ(@- ;8!.ZX9!'HCST RJ"42W:T_E9 M>L@"2.+/^WOR0(1Z[V!)=MEGN:.GCC., ;&NS]X&-\<\F>L-# +"M[J%3O52 M5*\ K=0S8F45Z'=5" 7W3M?PD-^M-\J\53HG<\E]02P,$% @ M-8K\5L):ET57!P VU< !4 !E;F]B+3(P,C,P-S(Q7W!R92YX;6S-G%US MXC84AN\[T__@TFL@D+;;9)/N)&S883:[24-VM^W-CK %:")+C"0'^/>5;,SR M8 +=*>?1,E6927+9ZG9-61$4L$R9FEZTOX_;5 M># :M2)MB$@(EX)>MH1LO?OKYY\B^W/Q2[L=#1GER7GT7L;MD9C*M]%GDM+S MZ ,55!$CU=OH*^&9VR*'C%,5#62ZX-10^T71\'GT>Z=W1J)V&U#O5RH2J;X\ MC+;USHU9Z/-N=[E<=H1\)DNIGG0GEBFLPK$A)M/;VDY6)YN?HO@%9^+IW/V: M$$TCRTOH\Y5FERW7[J;9Y6E'JEFW?W+2Z_[SZ78 F=G9]W\VU)ZI%Q-%"_;..V6W=G6;+]E ?U.3S0[UWGW;F5,3![VVF8BK\+] MURYE;;>IW>NW3WN=E4Y:)?R O.GGU?^Z)S+KA=TW-7.[5BOJ[C6]4%1387*W MMW;#7A&Z,G:/HDE9D6O_!9TSS#C]9I?I16VW?V6I; ZP!W M<9 ';LM].J>M:=R9R>=N0EG7$7 ? 5Y_=^M MYD#2;:!7)8E'6V-UI_85AWW:C=N5BB.I$JHLZ[(NHN*]:!WOGAM%=T&4K:AM M8\FW@9XJF?KH;$A(3T=W0=DFFJ%Y9=M/7!^&G,RJ<1Y(@#Q[&$ KW6 1?4]U MK-C"<:D!NZ<$\NVC\JWPUC#F\MAYH#/F^NNZXDZZU&T,CPN>(D#PIY@C1= M M4@2NA,@(?Z +J6K [RN!O'_#Y%WE#0GSWQE1ABJ^AI ^$@-A_XX)V^,0B?>C M(D(SQP<"_%@-)/X'ZH6'QR,2\O&< WF5'HC]#29VO\]7 /[FV9W? M[:D%SGZG"!#_GZ\%_Y%;I C<4\5D8D_I"L#^2 RD?H9)W>,0E?>-2*"TMU)P M_H,/^\ >$NHATS'A18^&=IL.XZZ00Y&CY)RU-E&Q_TN) D/?$4.1HZ2A-18; M!C[(E-KK3'!4\:NAR%$2T#J3#3._$8:9M;OS_SE+)S]NG.ZS/E9!&:,DG3Y3 M*&S+.PW"N <:(;Z'2BACE%PS9 Z%\\#Z482/1$)7'^DZ!/I("B6-DF,&[:&@ MOE 6BMS5>"_?1EV$_AV%%RT5J;F-@']N.=>I1+ MSQ-HKQB*'"47K;&("3P_T]RI>R6?63$SJH[Z40DH>L04-6P6=8 JN)*OU4.:(B6O(:-,W&(NXNYL6OJE$!Q(H7Y1< MM=).TTA=A!4E_MUW7P$%BI* 5IEIF.>M=,\^YE($[\<>JZ!<43))GZFF!UXW MEUA[#_V=K\$SV%"&U4,;#6/\IIBQ/1C(-,W$YAZ-YZF81PK%BY+^!>TUC'HL M.8N986+VR5XA*D9X-> S.YW&YQ0;J;CKUC;PA M/90X2JY7;Q27_$CKC*J7\J\H!8T"2MH'-=WT.$/CS Y[ZUY_\NA6S'A&F2,5 ME#5*RN _UHQKO@00*%B6S MJ[2#-"; :G&>KZS)[I>V+(IH A MIG'.K3LK^8.GUCT=E#=B8EIE#&?-5#;A+!YR28+7Y7LR*%_$++3"%@K>:R*> M5+8P\?I>R9A2]_A$;X\V0$($K :$L3\]$4H<&X7R#1UBXED_#2>6]/Z+C/Y M.TQM_X(W#8+EH*'!7,0),(YT%:1_+/2BR?7Z@4ZI &UL4$L! A0# M% @ -8K\5L):ET57!P VU< !4 ( !\2( &5N;V(M F,C R,S W,C%?<')E+GAM;%!+!08 ! $ ! ![*@ ! end